← All companies

GMED

Globus Medical, Inc.

GMED NYSE Surgical & Medical Instruments & Apparatus EDGAR ↗

$81.46

+1.20 +1.50%

Key statistics

from XBRL data in SEC filings

Market cap

$11.1B

Revenue (TTM)

$3.10B

Net income (TTM)

$587M

EPS (TTM)

$4.28

P/E ratio

19.0

Dividend yield

—

Free cash flow

$589M

Cash

$561M

Total assets

$5.44B

Gross margin

43.0%

52-week range

$52.56 – $101.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change; Regulation FD disclosure Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Results of operations (earnings release) Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jul 21, 2025 8-K Director or officer change; Shareholder vote results Jun 5, 2025 8-K Other events May 15, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Feb 6, 2025 8-K Results of operations (earnings release) Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Other events Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Results of operations (earnings release) Feb 20, 2024 8-K Director or officer change Feb 5, 2024 8-K Results of operations (earnings release) Jan 10, 2024 8-K/A Nov 15, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 8-K Entered a material agreement; Other events Oct 2, 2023 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Sep 1, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023